Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Dermatology

  Free Subscription


22.09.2025

2 Am J Dermatopathol
4 Am J Ophthalmol
1 Ann Intern Med
2 BMC Cancer
4 Br J Dermatol
2 Cancer Res
6 Clin Exp Dermatol
13 Eur J Dermatol
4 Int J Cancer
14 Int J Dermatol
2 Intern Med
1 J Cutan Pathol
12 J Dermatol
9 J Invest Dermatol
1 Mycoses
1 N Engl J Med
1 PLoS Biol
11 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. REDDY SG, Kemple KB, Potter KA, Powell MR, et al
    Fever, Weight Loss, and Cutaneous Nodules in an Immunocompromised Host: Challenge.
    Am J Dermatopathol. 2025 Sep 12. doi: 10.1097/DAD.0000000000003062.
    PubMed        

  2. NYKAZA I, Platero-Portillo T, Berman E, Geyer MB, et al
    Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective Cohort.
    Am J Dermatopathol. 2025 Sep 8. doi: 10.1097/DAD.0000000000003125.
    PubMed         Abstract available


    Am J Ophthalmol

  3. CHACKO JA, Chauhan MZ, Phillips PH, Ramakrishnaiah RH, et al
    Aortic and Carotid Complications in Patients With Giant Cell Arteritis.
    Am J Ophthalmol. 2025;278:65-72.
    PubMed         Abstract available

  4. MILLER S, Cano M, Kawalerski R, Shi MD, et al
    Elevated Lactic Acid Levels in the Aqueous Humor May Be an Indicator of Uveal Melanoma.
    Am J Ophthalmol. 2025 Sep 11:S0002-9394(25)00485.
    PubMed         Abstract available

  5. HOLLO G, Kita Y
    Comment on "OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association with Vision Loss".
    Am J Ophthalmol. 2025 Sep 8:S0002-9394(25)00473.
    PubMed        

  6. ZHANG R, Dong J, Li Y, Wu H, et al
    Reply to Comment on "OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Epiretinal Membrane".
    Am J Ophthalmol. 2025 Sep 5:S0002-9394(25)00474.
    PubMed        


    Ann Intern Med

  7. TERRIER B, Pugnet G, de Moreuil C, Bonnotte B, et al
    Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.
    Ann Intern Med. 2025;178:1249-1257.
    PubMed         Abstract available


    BMC Cancer

  8. LIAN W, Li L, Hong C, Chen D, et al
    Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study.
    BMC Cancer. 2025;25:1331.
    PubMed         Abstract available

  9. SREENATH ND, Pandalanghat S, Kapoor A, Govind R, et al
    A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort.
    BMC Cancer. 2025;25:1337.
    PubMed         Abstract available


    Br J Dermatol

  10. AHMED S, van Bodegraven B, Proby C, Harwood CA, et al
    Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20.
    Br J Dermatol. 2025 Sep 10:ljaf352. doi: 10.1093.
    PubMed         Abstract available

  11. SAMOTIJ D, Reich A
    Could TYK2 inhibition be a breakthrough in the effective treatment of cutaneous lupus erythematosus?
    Br J Dermatol. 2025 Sep 9:ljaf357. doi: 10.1093.
    PubMed        

  12. BASHALL SEL, Thomas BR, Sim V, Wain M, et al
    Primary Cutaneous CD4+ Small Medium T Cell Lymphoproliferative Disorder - 20 years of experience from a specialist centre.
    Br J Dermatol. 2025 Sep 8:ljaf338. doi: 10.1093.
    PubMed         Abstract available

  13. BOULANGER KP, McCuaig C, Roy AA, Kokta V, et al
    Striking improvement with targeted therapy in an ALK-positive atypical giant congenital melanocytic naevus of the right lower limb: a case report.
    Br J Dermatol. 2025 Sep 8:ljaf334. doi: 10.1093.
    PubMed        


    Cancer Res

  14. ZHAO Y, Andoh T, Charles F, Reddy P, et al
    A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.
    Cancer Res. 2025;85:3399-3415.
    PubMed         Abstract available

  15. TAO JJ, Vasan N
    A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast Cancer.
    Cancer Res. 2025;85:3371-3372.
    PubMed         Abstract available


    Clin Exp Dermatol

  16. JOEL MZ, Patel S, Kang J, Sunshine JC, et al
    Association of Autoimmune Disease with Melanoma and Non-Melanoma Skin Cancers.
    Clin Exp Dermatol. 2025 Sep 9:llaf409. doi: 10.1093.
    PubMed         Abstract available

  17. TSENG IL, Lee JY, Hsieh CC, Chen YC, et al
    When diagnostic clues are hidden in small blood vessels of the skin: Diagnostic challenge in Intravascular Large B-Cell Lymphoma.
    Clin Exp Dermatol. 2025 Sep 9:llaf413. doi: 10.1093.
    PubMed         Abstract available

  18. OKEAH IR, Siripanich CK, Chow YC, Ali FR, et al
    Post inflammatory hyperpigmentation following cutaneous surgery in skin of colour.
    Clin Exp Dermatol. 2025 Sep 8:llaf410. doi: 10.1093.
    PubMed        

  19. CLARK M, Wuennenberg J, Maghfour J, Jones B, et al
    Reflectance Confocal Microscopy for Monitoring Treatment Response in Superficial Basal Cell Carcinoma: Diagnostic Challenges Due to Scar Formation.
    Clin Exp Dermatol. 2025 Sep 8:llaf407. doi: 10.1093.
    PubMed         Abstract available

  20. POTESTIO L, Patruno C, di Vico F, Lizzi L, et al
    Real-world effectiveness of lebrikizumab on pruritus in moderate-to-severe atopic dermatitis: preliminary data from a single-center, real-life experience.
    Clin Exp Dermatol. 2025 Sep 8:llaf411. doi: 10.1093.
    PubMed        

  21. FASTENAU A, Willis M, Chahal P, Schlumberger F, et al
    The Challenges of Integrating Skin NTDs in Pakistan: A Gap Between Recommendations and Realities.
    Clin Exp Dermatol. 2025 Sep 6:llaf415. doi: 10.1093.
    PubMed        


    Eur J Dermatol

  22. YAMAMOTO T, Matsuda KM, Yamada D, Yoshizaki-Ogawa A, et al
    Generalized pustular psoriasis with purpura and haemorrhagic blisters.
    Eur J Dermatol. 2025;35:313-314.
    PubMed        

  23. AKASHI N, Ogawa-Momohara M, Nakaguro M, Noda E, et al
    Polyarteritis nodosa with cutaneous manifestations localized to the upper limb, possibly caused by trauma.
    Eur J Dermatol. 2025;35:314-316.
    PubMed        

  24. PIRES DA ROSA G, Brito I, Mota A
    Successful treatment of refractory cutaneous involvement of NXP2-positive dermatomyositis with intravenous immunoglobulins.
    Eur J Dermatol. 2025;35:324-325.
    PubMed        

  25. YAO S, Fukui T, Rokunohe D, Jin K, et al
    A Japanese case of lichen planus pigmentosus-inversus: the importance of friction avoidance and dermoscopy.
    Eur J Dermatol. 2025;35:335-336.
    PubMed        

  26. GUITERA P, Navarrete-Dechent C, Benzaquen M, Polesie S, et al
    Artificial intelligence-enhanced skin self-examinations for skin cancer detection- potential benefits and challenges: insights from an international multidisciplinary expert meeting.
    Eur J Dermatol. 2025;35:337-338.
    PubMed        

  27. ELINKICHARI D, Tabka M, Souissi A, Mokni M, et al
    sQUIZ your knowledge! Large pustules with hypopyon revealing an acantholytic dermatosis.
    Eur J Dermatol. 2025;35:350-351.
    PubMed        

  28. ZULAIKA-LLORET M, De La Torre-Gomar FJ, Ruiz-Villaverde R
    sQUIZ your knowledge! Linear pinkish-orange papules on the forearms.
    Eur J Dermatol. 2025;35:353-354.
    PubMed        

  29. ZHANG S
    sQuiz your knowledge! Pruritic erythematous follicular papules on the neck.
    Eur J Dermatol. 2025;35:357-358.
    PubMed        

  30. SUN J, Wang Z, Xu Z
    Secukinumab-induced erythema multiforme-like drug eruption in generalized pustular psoriasis: a case report and literature review.
    Eur J Dermatol. 2025;35:279-284.
    PubMed         Abstract available

  31. MEDINA-VICENT NA, Porras-Lopez C, Frias-De-Leon MG, Vega-Sanchez DC, et al
    Epidemiological analysis of dermatophytomas over 15 years in Mexico: is the concept correct for all fungi?
    Eur J Dermatol. 2025;35:285-293.
    PubMed         Abstract available

  32. ABDUSALAMOVA K, Kinberger M, Globig P, Worm M, et al
    Clinical features and treatment of morphea patients: a retrospective analysis.
    Eur J Dermatol. 2025;35:294-299.
    PubMed         Abstract available

  33. FISEK IZCI N, Aksoy B, Aktas E
    Significant impact of telogen effluvium on quality of life, depression, anxiety and stress: a prospective case-control study.
    Eur J Dermatol. 2025;35:300-306.
    PubMed         Abstract available

  34. ZHANG C, He W, Cao Q, Ge H, et al
    Six cases of ectopic cutaneous ossification associated with GNAS gene variants.
    Eur J Dermatol. 2025;35:307-312.
    PubMed         Abstract available


    Int J Cancer

  35. MENZ BD, Modi ND, Abuhelwa AY, Kuderer NM, et al
    Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials.
    Int J Cancer. 2025 Jun 21. doi: 10.1002/ijc.70020.
    PubMed         Abstract available

  36. WEI SQ, Leduc V, Potter B, Paradis G, et al
    Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology.
    Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.70025.
    PubMed         Abstract available

  37. JIA G, Ping J, Tao R, Long J, et al
    Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci.
    Int J Cancer. 2025 Jul 14. doi: 10.1002/ijc.70041.
    PubMed         Abstract available

  38. RASHID MU, Muhammad N, Arif S, Naeemi H, et al
    Genetic landscape of Pakistani familial breast cancer patients using multigene panel testing.
    Int J Cancer. 2025 Aug 1. doi: 10.1002/ijc.70070.
    PubMed         Abstract available


    Int J Dermatol

  39. DIXIT I, Mansilla-Polo M, Kim J, Fernandez-Penas P, et al
    Successful Treatment of Refractory Dermatitis Herpetiformis With Upadacitinib.
    Int J Dermatol. 2025 Sep 9. doi: 10.1111/ijd.70067.
    PubMed        

  40. SECHI A, Tartaglia J, Ponzano M, Ciolfi C, et al
    Clinical and Dermoscopic Characterization of Scalp Cutaneous Metastases From Breast Carcinoma: A Multicenter Study of the EADV Task Force on Hair Diseases.
    Int J Dermatol. 2025 Sep 10. doi: 10.1111/ijd.70059.
    PubMed         Abstract available

  41. ARA-MARTIN M, Moreno C, Ruiz-Villaverde R, Serra-Baldrich E, et al
    Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors.
    Int J Dermatol. 2025 Sep 10. doi: 10.1111/ijd.70033.
    PubMed         Abstract available

  42. TSHUVA R, Bomze D, Sprecher E, Samuelov L, et al
    Real-World Efficacy and Safety of Dupilumab for Atopic Dermatitis in the Israeli Population.
    Int J Dermatol. 2025 Jul 13. doi: 10.1111/ijd.17969.
    PubMed        

  43. MCMULLEN E, Joseph M, Mannala S, Metko D, et al
    Misdiagnoses of Hair and Scalp Disorders in Adult Patients With Skin of Color.
    Int J Dermatol. 2025 Jul 4. doi: 10.1111/ijd.17899.
    PubMed        

  44. MRUWAT N, Givon-Lavi N, Ludwig RJ, Kridin K, et al
    The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study.
    Int J Dermatol. 2025 Jul 7. doi: 10.1111/ijd.17923.
    PubMed        

  45. LI X, Li W, Chen W, Liu H, et al
    Global, Regional, and National Burden and Trends of Pediatric Psoriasis: Insights From the Global Burden of Disease Study 2021.
    Int J Dermatol. 2025 Jul 16. doi: 10.1111/ijd.17958.
    PubMed        

  46. JOSHI TP, Gupta R, Nijhawan RI
    Clinical Characteristics and Disease-Specific Survival of Patients With Balloon Cell Melanoma: A Study of 118 Cases.
    Int J Dermatol. 2025 Jul 23. doi: 10.1111/ijd.17983.
    PubMed        

  47. AMJAD SA, Cravero K, Marks LA, Degesys CA, et al
    Representation of Skin of Color in Cutaneous Oncology Publications: A Decade of Trends and Disparities.
    Int J Dermatol. 2025 Aug 14. doi: 10.1111/ijd.70011.
    PubMed        

  48. O'REILLY D, Murray G, Fitzpatrick OM, Ismail H, et al
    Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies.
    Int J Dermatol. 2025 Sep 12. doi: 10.1111/ijd.70061.
    PubMed         Abstract available

  49. TRAGER A, Esfandiari N, Goncharuk V, Custer T, et al
    Aquagenic Wrinkling of the Cutaneous Lip: A Case Report.
    Int J Dermatol. 2025 Sep 12. doi: 10.1111/ijd.70077.
    PubMed        

  50. MARONESE CA, Derlino F, Termini D, Buffon S, et al
    Fatal Toxic Epidermal Necrolysis-Like Lupus Erythematosus in a Patient With Metastatic Histiocytic Sarcoma.
    Int J Dermatol. 2025 Sep 13. doi: 10.1111/ijd.70072.
    PubMed        


  51. Correction to "A Comparative Case-Control Study of Diagnostic Criteria for Atopic Dermatitis and Proposal of New Diagnostic Criteria From Tunisia".
    Int J Dermatol. 2025 Sep 14. doi: 10.1111/ijd.70073.
    PubMed        

  52. FAYOS GREGORI R, Mansilla-Polo M, Lopez Davia J, Martinez-Cozar V, et al
    Toxic Epidermal Necrolysis-Like Syndrome Following CAR-T Therapy: A Case Report and Review of Distinctive Clinical Features.
    Int J Dermatol. 2025 Sep 17. doi: 10.1111/ijd.70078.
    PubMed        


    Intern Med

  53. HISAMOTO Y, Murata Y, Matsuda K, Narikiyo K, et al
    Bucillamine-induced Yellow Nail Syndrome with Chylothorax.
    Intern Med. 2025;64:2755-2759.
    PubMed         Abstract available

  54. ARITAKE H, Miyauchi E, Kyogoku Y, Aizawa H, et al
    A Case of Acetaminophen-induced Toxic Epidermal Necrolysis with Airway Mucosal Lesions.
    Intern Med. 2025 Sep 11. doi: 10.2169/internalmedicine.6078.
    PubMed         Abstract available


    J Cutan Pathol

  55. PIEROG O, Estill M, Jedrych J, Rozati S, et al
    The Overlapping Clinicopathological Presentations of Pityriasis Lichenoides and Mycosis Fungoides.
    J Cutan Pathol. 2025 Sep 15. doi: 10.1111/cup.14856.
    PubMed         Abstract available


    J Dermatol

  56. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17938.
    PubMed         Abstract available

  57. ZHANG Y, Cheng C, Xu Z, Yang D, et al
    Indole-3-Lactic Acid Inhibits Keratinocyte Proliferation Through the Aryl Hydrocarbon Receptor in Psoriasis.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17947.
    PubMed         Abstract available

  58. AHN HK, Oh S, Yoon HS
    Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17949.
    PubMed         Abstract available

  59. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    PubMed         Abstract available

  60. TAKAMURA S, Saito S, Sugai S, Shiko Y, et al
    Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17950.
    PubMed         Abstract available


  61. Correction to "A Case of Metastasis of Giant Basal Cell Carcinoma in Oculocutaneous Albinism".
    J Dermatol. 2025 Sep 9. doi: 10.1111/1346-8138.17955.
    PubMed        

  62. ZHOU W, Cao Y, Wu C, Zhou K, et al
    Should Be Removed or Taken Biopsy in Early Stage: A Retrospective Study of 953 Cases of Nevus Sebaceous From a Single Center.
    J Dermatol. 2025 Sep 10. doi: 10.1111/1346-8138.17941.
    PubMed         Abstract available

  63. YAMADA K, Imanishi H, Mine M, Kunimoto H, et al
    Establishment of a Nail Psoriasis Mouse Model by Topical Application of Imiquimod After Nail Removal.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17956.
    PubMed         Abstract available

  64. KATO K, Kato H, Magara T, Morita A, et al
    Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17958.
    PubMed         Abstract available

  65. MATSUOKA K, Nakamura Y, Miki H, Nomura T, et al
    Cutaneous Metaplastic Synovial Cyst With Immunohistochemical Studies for Synovial Cell Markers: A Case Report.
    J Dermatol. 2025 Sep 17. doi: 10.1111/1346-8138.17969.
    PubMed        

  66. TAKAHASHI Y, Hagino T, Saeki H, Fujimoto E, et al
    A 104-Week Real-World Outcome of Bimekizumab Treatment for Psoriasis: Biologic-Naive Versus -Experienced Patients.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17962.
    PubMed         Abstract available

  67. MUTO Y, Fujihara M, Ogawa Y, Oishi N, et al
    Case of Primary Cutaneous Gamma-Delta T-Cell Lymphoma in Which Brentuximab Vedotin-Based Polychemotherapy Failed to Achieve Durable Remission.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17967.
    PubMed        


    J Invest Dermatol

  68. CHOI W, Park DJ, Dorschner RA, Pool K, et al
    Regulated release of small extracellular vesicles directs neutrophil recruitment in cutaneous wound healing.
    J Invest Dermatol. 2025 Sep 4:S0022-202X(25)02411.
    PubMed         Abstract available

  69. SAUERLAND MB, Karakaya T, Haulrig MB, Lovendorf MB, et al
    Scalable Acid-Aided Lysis of Skin Samples Improves Proteome Coverage.
    J Invest Dermatol. 2025 Sep 4:S0022-202X(25)02410.
    PubMed         Abstract available

  70. BURSHTEIN J, Bunick CG, Vleugels RA, Armstrong AW, et al
    Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy.
    J Invest Dermatol. 2025 Sep 6:S0022-202X(25)02338.
    PubMed        

  71. DANESH K, Lin FJ, Chen HL, Liu FT, et al
    Galectins in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential.
    J Invest Dermatol. 2025 Sep 8:S0022-202X(25)02330.
    PubMed         Abstract available

  72. GALLO RL
    Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02325.
    PubMed        

  73. WEI J, Wang Y, Chen Y, Wang Z, et al
    Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis.
    J Invest Dermatol. 2025 Sep 8:S0022-202X(25)02415.
    PubMed         Abstract available

  74. SMITH CJ, Al-Salihi A, Williams JL, Chan L, et al
    Reduced PPOX expression causes intrinsic pathogenicity in keratinocytes, contributing to the cutaneous Variegate Porphyria phenotype.
    J Invest Dermatol. 2025 Sep 9:S0022-202X(25)02418.
    PubMed         Abstract available

  75. BASH GN, Baghoomian W, Seshadri R, Latour E, et al
    Aberrant Epidermal Innervation in Adults with Atopic Dermatitis is Restored Following Dupilumab Treatment.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02424.
    PubMed        

  76. SUN M, Guo P, Guo Q, Li H, et al
    Inducible Nitric Oxide Deficiency Attenuates Necroptosis in Psoriasis-like Dermatitis in Mice through Reducing Oxidative Stress.
    J Invest Dermatol. 2025 Sep 15:S0022-202X(25)02428.
    PubMed         Abstract available


    Mycoses

  77. TAN Y, Shao Y, Li T, Hu X, et al
    The Effect of Topical Ketoconazole and Topical Miconazole Nitrate in Modulating the Skin Microbiome and Mycobiome of Patients With Tinea Pedis.
    Mycoses. 2025;68:e70116.
    PubMed         Abstract available


    N Engl J Med

  78. OKADA S, Nishikubo M
    Subcutaneous Panniculitis-like T-Cell Lymphoma.
    N Engl J Med. 2025;393:1117.
    PubMed        


    PLoS Biol

  79. ANSARI MN, Jha SK, Khan A, Rajput K, et al
    The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms.
    PLoS Biol. 2025;23:e3003362.
    PubMed         Abstract available


    PLoS One

  80. HERNANDEZ N, Pakarinen T, Salminen A, Castro SL, et al
    A systematic approach to study the effects of acquisition parameters and biological factors on computerized mammography analysis using ex vivo human tissue: A protocol description.
    PLoS One. 2025;20:e0321658.
    PubMed         Abstract available

  81. TOLD R, Reumueller A, Kreminger J, Sacu S, et al
    Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis.
    PLoS One. 2025;20:e0328360.
    PubMed         Abstract available

  82. KOSHAREK AT, Zuleger CL, Glass WS, Eickhoff J, et al
    In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma.
    PLoS One. 2025;20:e0330200.
    PubMed         Abstract available

  83. RAHIMZADEH S, Bentham J, Burczynska B, Farzadfar F, et al
    Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mapping.
    PLoS One. 2025;20:e0330017.
    PubMed         Abstract available

  84. JEWETT P, Solomon M, Brown K, Flanagan D, et al
    Sun protection behavior beliefs among adults living in rural United States: A qualitative study in Minnesota.
    PLoS One. 2025;20:e0331685.
    PubMed         Abstract available

  85. THARMARAJAH S, Abideen Z, Hussain S, Guilcher SJT, et al
    Real-world trends in rheumatic disease rates among pregnancies in Ontario, Canada: A repeated cross-sectional study.
    PLoS One. 2025;20:e0332374.
    PubMed         Abstract available

  86. NIKHILA L, Surya S, Najeeb SH, Binumon TM, et al
    Disrupted cholesterol biosynthesis and hair follicle stem cell impairment in the onset of alopecia.
    PLoS One. 2025;20:e0308455.
    PubMed         Abstract available

  87. ABDEL-HAMID L, Yogarajah P, Tealab SHA
    Lightweight deep models based on domain adaptation and network pruning for breast cancer HER2 scoring: IHC vs. H&E histopathological images.
    PLoS One. 2025;20:e0332362.
    PubMed         Abstract available

  88. HUNDLEY WW, O'Connell NS, Kirkman DL, Olson KC, et al
    Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213.
    PLoS One. 2025;20:e0318017.
    PubMed         Abstract available

  89. SHEHATA N, Banaganapalli B, Al Mahdi HB, Alghuraibi S, et al
    Identifying novel genetic variants in epidermolysis Bullosa among Middle Eastern Arab Families: Insights from whole exome sequencing and computational analysis.
    PLoS One. 2025;20:e0328296.
    PubMed         Abstract available

  90. PRADO SOUSA AC, Duran-Prado M, Villar M, Gonzalez-Garcia A, et al
    Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro.
    PLoS One. 2025;20:e0331779.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  91. SAGLIMBENI J, Esteva E, Canales J, Perez OA, et al
    Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2504645122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.